Intratumoral Combinatorial Administration of CD1c (BDCA-1)(+) Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial

Schwarze, JK; Awada, G; Cras, L; Tijtgat, J; Forsyth, R; Dufait, I; Tuyaerts, S; Van Riet, I; Neyns, B

Schwarze, JK (corresponding author), Univ Ziekenhuis Brussel, Dept Med Oncol, Laarbeeklaan 101, B-1090 Brussels, Belgium.

VACCINES, 2020; 8 (4):

Abstract

Intratumoral (IT) myeloid dendritic cells (myDCs) play a pivotal role in re-licensing antitumor cytotoxic T lymphocytes. IT injection of the IgG(1) mo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索